Stocks
Heron Therapeutics (HRTX) Debt/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| Debt/EBITDA | -0.01 | -0.41 | -0.96 | -23.4 | -5.26 | -4.71 | ||
| Changes by years, y/y, % | -101% | +4 521% | +133% | +2 351% | -78% | |||
Heron Therapeutics. Debt/EBITDA
Heron Therapeutics. Debt/EBITDA, changes, %
Heron Therapeutics (HRTX) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 45.9 | 18.1 | -33.1 | -7.77 | -4.71 | -4.71 | ||
| Changes by years, y/y, % | -3 321% | -744% | +497% | -67% | -110% | |||
| Changes by quarters, q/q, % | -296% | -61% | -283% | -77% | -39% | |||
